NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘pharmaceuticals’

11 August 2014

Business Growth Fund invests £2m in UK buy-and-build pharma company

pills-1111307-m British investment firm the Business Growth Fund has invested £2m in specialist pharmaceutical company Abbey Pharma.

8 August 2014

Beringea exits pharmaceutical company Altacor after seven years

Cataract-surgery UK-bases growth capital investor Beringea has sold its investment in specialty ophthalmology company Altacor to Dutch life sciences investment firm Esperante after seven years of ownership.

4 August 2014

KKR, Warburg Pincus among suitors for GSK, Sanofi drugs

pills Private equity firms are reportedly planning to buy older drugs from pharmaceutical groups GlaxoSmithKline and Sanofi and merge them.

1 August 2014

Polaris hires ex-Pfizer exec Amy Schulman as venture partner

schulman Boston-based investment firm Polaris Partners has hired ex-Pfizer executive Amy Schulman as a venture partner.

28 July 2014

Sanofi’s $8.5bn mature drug portfolio draws private equity interest

green pills A trio of private equity majors are reportedly interested in French pharmaceutical company Sanofi’s $8.5bn portfolio of older, off-patent drugs.

18 July 2014

Biotech startup InflaRx closes Series B round

clinical development Biotech startup InflaRx has closed its Series B round, which reached the “double digit million Euro space.”

18 July 2014

Roka Bioscience raised $60m via Nasdaq IPO

biotech Venture capital-backed molecular diagnostics specialist Roka Bioscience has raised $60m via an IPO on the Nasdaq exchange.

27 June 2014

EMX Capital backs Farmapiel with $28m investment

mexico Mexican private equity fund EMX Capital has agreed to invest up to MXN370m ($28m) in pharmaceutical company Farmapiel.

24 June 2014

Carlyle invests in Sunsho Pharmaceutical from third Japanese fund

fujiyama Private equity major Carlyle has bought Japanese health and nutrition (H&N) and pharmaceutical products maker Sunsho Pharmaceutical.

23 June 2014

Luye Pharma’s private equity backers look to raise $761m via Hong Kong IPO

hong kong The private equity backers of Luye Pharma Group are reportedly looking to raise as much as HK$5.9bn ($761m) in the IPO of the Chinese drug maker.

Page 1 of 512345

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014